Katherine Stueland
Director, CHIEF EXECUTIVE OFFICER · 3 filings · Latest: Apr 29, 2026
GeneDx Holdings Corp.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
WGS | Katherine Stueland | Director, CHIEF EXECUTIVE OFFICER | Apr 29, 2026 | Sale | $65.19 | 2,172 | $141.6K | 93,216 | |
WGS | Katherine Stueland | Director, CHIEF EXECUTIVE OFFICER | Apr 29, 2026 | Option Exercise | $0.00 | 3,874 | — | 95,388 | |
WGS | Katherine Stueland | Director, CHIEF EXECUTIVE OFFICER | Mar 26, 2026 | Sale | $63.17 | 46,933 | $3.0M | 91,514 | |
WGS | Katherine Stueland | Director, CHIEF EXECUTIVE OFFICER | Mar 26, 2026 | Option Exercise | $0.00 | 80,000 | — | 138,447 | |
WGS | Katherine Stueland | Director, CHIEF EXECUTIVE OFFICER | Mar 16, 2026 | Sale | $76.80 | 17,179 | $1.3M | 58,447 | |
WGS | Katherine Stueland | Director, CHIEF EXECUTIVE OFFICER | Mar 16, 2026 | Option Exercise | $0.00 | 18,750 | — | 75,626 | |
WGS | Katherine Stueland | Director, CHIEF EXECUTIVE OFFICER | Mar 15, 2026 | Option Exercise | $0.00 | 11,921 | — | 56,876 |